common.study.topics.clinical

Platelet Transfusion in Hematopoietic Transplantation

common.study.values.description

Platelet Transfusion Requirements in Hematopoietic Transplantation

It is hypothesized that a strategy using prophylactic oral Tranexamic Acid (TXA) with therapeutic platelet transfusions is safe and effective compared to prophylactic platelet transfusions in patients undergoing an autologous hematopoietic stem cell transplantation (who are at risk for bleeding).

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Recruiting patients only common.study.methods.is-healthy-yes

Drug - Tranexamic Acid

participant.views.study.view.additional

participant.views.study.view.scientific-title

Platelet Transfusion Requirements in Hematopoietic Transplantation(PATH Pilot)

common.study.values.clinical-trial-id

NCT02650791

participant.views.study.view.id

9aAWjd